| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 13785 |
| 1 | ADALIMUMAB | 10142 |
| 2 | DUPILUMAB | 6113 |
| 3 | EVOLOCUMAB | 4954 |
| 4 | TERIPARATIDE | 4794 |
| 5 | TIRZEPATIDE | 3941 |
| 6 | METHOTREXATE SODIUM | 3660 |
| 7 | METHOTREXATE | 3621 |
| 8 | PREDNISONE | 2720 |
| 9 | INTERFERON BETA-1A | 2587 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | REPOSITORY CORTICOTROPIN | 385 | 0.0863 |
| 1 | ERGOCALCIFEROL | 2351 | 0.0791 |
| 2 | TESAMORELIN | 99 | 0.0585 |
| 3 | ASFOTASE ALFA | 513 | 0.0497 |
| 4 | TERIPARATIDE | 4794 | 0.0426 |
| 5 | ABALOPARATIDE | 1289 | 0.0415 |
| 6 | GLATIRAMER ACETATE INJECTION | 183 | 0.0389 |
| 7 | EXENATIDE | 1843 | 0.0352 |
| 8 | COLLAGENASE CLOSTRIDIUM HISTOLYTICUM | 191 | 0.0352 |
| 9 | ALIROCUMAB | 905 | 0.0351 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 15191 |
| 1 | GLP-1 Receptor Agonist [EPC] | 8542 |
| 2 | Interleukin-4 Receptor alpha Antagonist [EPC] | 6113 |
| 3 | PCSK9 Inhibitor [EPC] | 5820 |
| 4 | Parathyroid Hormone Analog [EPC] | 4794 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 4694 |
| 6 | Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] | 3941 |
| 7 | Corticosteroid [EPC] | 3935 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 3513 |
| 9 | Insulin Analog [EPC] | 3097 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Adrenocorticotropic Hormone [EPC] | 390 | 0.4358 |
| 1 | Interleukin-5 Antagonist [EPC] | 164 | 0.2384 |
| 2 | PCSK9 Inhibitor [EPC] | 5820 | 0.2260 |
| 3 | Provitamin D2 Compound [EPC] | 2351 | 0.0790 |
| 4 | Interleukin-17A Antagonist [EPC] | 2513 | 0.0674 |
| 5 | Melanocortin 4 Receptor Agonist [EPC] | 19 | 0.0667 |
| 6 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 513 | 0.0497 |
| 7 | Parathyroid Hormone Analog [EPC] | 4794 | 0.0426 |
| 8 | Parathyroid Hormone-Related Peptide Analog [EPC] | 1289 | 0.0415 |
| 9 | Cytolytic Agent [EPC] | 76 | 0.0326 |